World's Best Scientists 2026 revealed!
Damian F. J. Purcell

Damian F. J. Purcell

D-Index & Metrics

Immunology

D-Index
47
Citations
6757
World Ranking
4556
National Ranking
196

Overview

Damian F. J. Purcell is affiliated with the University of Melbourne in Australia. Their research primarily focuses on medicine, particularly in infectious diseases, immunology, and microbiology. The subfields of study they contribute to include infectious diseases, immunology, molecular biology, agronomy and crop science, and epidemiology.

The main topics covered by Purcell's research include SARS-CoV-2 and COVID-19 research, SARS-CoV-2 detection and testing, COVID-19 clinical research studies, animal disease management and epidemiology, viral gastroenteritis research and epidemiology, HIV research and treatment, and T-cell and retrovirus studies.

Frequent co-authors collaborating with Purcell are:

  • Julie McAuley (28 joint publications)
  • Dale I. Godfrey (22 joint publications)
  • Samantha L. Grimley (21 joint publications)
  • Kanta Subbarao (20 joint publications)
  • Francesca L. Mordant (18 joint publications)

Purcell has published extensively in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory) with 10 publications
  • EBioMedicine with 4 publications
  • Viruses with 4 publications
  • Nature Communications with 3 publications
  • Journal of Virology with 3 publications

Key recent publications by Damian F. J. Purcell include:

  • Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice, 2021, Proceedings of the National Academy of Sciences
  • SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon, 2021, PLoS Pathogens
  • Direct RNA sequencing and early evolution of SARS-CoV-2, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial, 2021, The Lancet Infectious Diseases
  • Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting, 2020, The Journal of Infectious Diseases

Best Publications

  • Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

    Damian F. J. Purcell;Malcolm A. Martin

  • Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

    Secondo Sonza;Helen P. Mutimer;Robert Oelrichs;Darren Jardine

  • Astrocyte infection by HIV-1: Mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia

    Paul R. Gorry;Chi Ong;Janine Thorpe;Sylvie Bannwarth

  • Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues

    Melissa J Churchill;Paul R Gorry;Paul R Gorry;Paul R Gorry;Daniel Cowley;Luxshimi Lal

  • Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).

    Christopher H. Holmes;Karen L. Simpson;Hidechika Okada;Noriko Okada

  • Characterization of the TRBP domain required for Dicer interaction and function in RNA interference

    Sylvanne M Daniels;Carlos E Melendez-Peña;Robert J Scarborough;Aïcha Daher

  • Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.

    Phillip Pymm;Phillip Pymm;Amy Adair;Li-Jin Chan;Li-Jin Chan;James P Cooney;James P Cooney

  • CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells

    Sonia Fernandez;Sara Tanaskovic;Karla Helbig;Reena Rajasuriar

  • Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression.

    Aı̈cha Daher;Michèle Longuet;Dominique Dorin;Florence Bois

  • Diminished Production of Human Immunodeficiency Virus Type 1 in Astrocytes Results from Inefficient Translation of gag, env, and nef mRNAs despite Efficient Expression of Tat and Rev

    Paul R. Gorry;Jane L. Howard;Melissa J. Churchill;Jenny L. Anderson

  • Tissue‐specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing

    Sarah M. Russell;Rosemary L. Sparrow;Ian F. C. McKenzie;Damian F. J. Purcell

  • SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

    Maya Shemesh;Turgut E. Aktepe;Joshua M. Deerain;Julie L. McAuley

  • Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells

    Suha Saleh;Suha Saleh;Fiona Wightman;Fiona Wightman;Saumya Ramanayake;Marina Alexander

  • An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer.

    D. F. J. Purcell;C. M. Broscius;E. F. Vanin;C. E. Buckler

  • The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46.

    D. F. J. Purcell;I. F. C. Mckenzie;D. M. Lublin;P. M. Johnson

  • Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.

    Keith J Chappell;Francesca L Mordant;Zheyi Li;Danushka K Wijesundara

  • Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response

    Chi L. Ong;Janine C. Thorpe;Paul R. Gorry;Sylvie Bannwarth

  • Direct RNA sequencing and early evolution of SARS-CoV-2

    George Taiaroa;George Taiaroa;Daniel Rawlinson;Leo Featherstone;Miranda Pitt

  • Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

    Jasminka Sterjovski;Jasminka Sterjovski;Melissa Churchill;Melissa Churchill;Anne Ellett;Lachlan Robert Gray;Lachlan Robert Gray

  • Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.

    Damian F. J. Purcell;Sarah M. Russell;Nicholas J. Deacon;Melissa A. Brown

  • An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

    Elisa Vicenzi;Dimiter S. Dimitrov;Alan Engelman;Thi Sau Migone

  • Small Interfering RNAs against the TAR RNA Binding Protein, TRBP, a Dicer Cofactor, Inhibit Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression and Viral Production

    Helen S. Christensen;Aïcha Daher;Kaitlin J. Soye;Lisa B. Frankel

  • Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication

    Paul Gorry;Damian Purcell;Jane Howard;Dale Mcphee

Frequent Co-Authors

Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Paul R. Gorry
Paul R. Gorry RMIT University
Stephen J. Kent
Stephen J. Kent University of Melbourne
Steven Lodewyk Wesselingh
Steven Lodewyk Wesselingh South Australian Health and Medical Research Institute
Ian F. C. McKenzie
Ian F. C. McKenzie University of Melbourne
Dale I. Godfrey
Dale I. Godfrey University of Melbourne
Kanta Subbarao
Kanta Subbarao University of Melbourne
Adam K. Wheatley
Adam K. Wheatley University of Melbourne
Anthony D. Kelleher
Anthony D. Kelleher University of New South Wales
Katherine Kedzierska
Katherine Kedzierska University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, pursuing related healthcare degrees can open up diverse career opportunities. Nursing roles, particularly psychiatric and acute care specialties, are in high demand. Students interested in mental health can explore the top pmhnp programs, which offer strong clinical placement rates essential for gaining practical experience. Affordability is a significant factor when choosing a program; thus, evaluating the cheapest psychiatric nurse practitioner programs can help manage education costs without sacrificing quality.

Nursing careers provide lucrative prospects, especially at advanced practice levels. Understanding the highest paid dnp specialties can guide students toward financially rewarding paths within nursing and healthcare leadership roles. For current Family Nurse Practitioners (FNPs) aiming to specialize, there are efficient pathways like the fnp to acnp bridge program online, which facilitates smooth transitions into acute care nursing.

By aligning immunology knowledge with these related healthcare credentials, graduates can expand their skill sets and career options in dynamic, well-compensated fields that address complex patient needs.

Best Scientists Citing Damian F. J. Purcell

Trending Scientists

Recently Published Articles